Navigation Links
Novavax Reports First Quarter 2008 Financial Results
Date:5/9/2008

e second half of 2008, we expect to have two vaccines in Phase II clinical trials, progress our varicella zoster program into preclinical studies, and announce our fourth vaccine program-all of which reflect a rapid advancement of our vaccine pipeline."

2008 Financial Results

Revenue from continuing operations, for the first quarter ended March 31, 2008 was $0.5 million compared to $0.5 million for the same period in 2007, essentially no change from prior year. The change year over year was primarily due to higher research revenues in 2008 offset by lower Gynodiol sales in 2007 due to the discontinued sale of the product in mid-2007.

There were no costs of products sold from continuing operations in the first quarter of 2008 due to the classification of Estrasorb manufacturing into discontinued operations, as compared to $50,000 in 2007 related to Gynodiol sales.

Research and development costs for the first quarter of 2008 were $4.4 million compared to $3.7 million in the first quarter of 2007, an increase of $0.7 million or 21.4%. The increase in the first quarter of 2008 as compared to 2007 was due to higher research and development spending to support the Company's pandemic influenza vaccine clinical trials, as well as additional pre-clinical studies for our seasonal influenza program in the first quarter of 2008. These increases were primarily for increased personnel, facility costs and outside expenses (including sponsored research, clinical research organization costs and consulting agreements) associated with expanded preclinical studies, human trial study costs, testing and process development, manufacturing and quality-assurance and quality-control related activities.

General and administrative costs were $3.2 million in the first quarter of 2008 as compared to $4.6 million in the prior year. The decrease of $1.4 million in the first quarter of 2008 as compared to the first quarter of 2007 was principally due to the follow
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 4, 2015  Blueprint Medicines (NASDAQ: BPMC ... kinase drugs for genomically defined diseases, today announced that ... a company overview at the 2015 Wedbush PacGrow Healthcare ... EDT. A live webcast of the event ... the Blueprint Medicines website at www.blueprintmedicines.com . An ...
(Date:8/4/2015)... 4, 2015   California Cryobank Stem Cell Services ... LifeLine Cryogenics, an east coast cord blood and reproductive ... tristate area. LifeLine clients will maintain full ... will be honored. Since 1991, LifeLine has ... of sperm, eggs, embryos, and cord blood stem cells. LifeLine ...
(Date:8/3/2015)... N.C. , Aug. 3, 2015  ArroGen ... unveil its new Fingerprint Molecular Identification™ (FMID) technology ... educational conference in Sacramento, Calif. ... forensic science, will enable law enforcement agents, district ... profile of criminal suspects. By analyzing ...
(Date:8/3/2015)... London, UK (PRWEB) , ... August 03, 2015 ... ... largest consumer of benzene. Benzene is processed to get such derivatives as ethylbenzene, ... Ethylbenzene derivatives are principally used within the automotive industry for the production of ...
Breaking Biology Technology:FamilyCord Announces Acquisition of LifeLine Cryogenics 2ArroGen Previews New Fingerprint Molecular Identification Technology 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 3
... Sept. 9 Lentigen Corporation,announced today that ... and manufacturing from the University of Maryland ... 200 South Building, Gaithersburg, MD,20878 (Tel: 301.527.4200)., ... the almost 26,000,square-foot facility will accommodate Lentigen,s ...
... 3rd Largest Biotech Cluster By ... Developing more than 175 Local Companies, SAN DIEGO, Sept. ... Reunion for Hybritech employees will,take place on Saturday, September 13th, ... In September 1978 Hybritech, San Diego,s "Granddaddy" biotech company,began operations ...
... TUSTIN, Calif., Sept. 9 ( http://www.amdl.com ),AMDL, Inc. ... with major operations in China and the US, today ... an interview with Mr.,Gary Dreher, President and CEO of ... 2008. A copy of the interview is available in ...
Cached Biology Technology:Lentigen Corporation Announces Relocation to New Facility 2San Diego's Original Biotech Company Celebrates 30th Anniversary With Reunion 2The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue 2
(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... by a Texas A&M University professor have discovered coral ... than 4,200 years old, making them among the oldest ... Brendan Roark of Texas A&M,s College of Geosciences, and ... National University in Canberra, have had their work published ...
... 120 researchers will speak at The EMBO Meeting 2009 ... organized by the European Molecular Biology Organization (EMBO) and ... 2009. The EMBO Meeting 2009 advances the ... high-resolution approaches of modern biological research. It follows on ...
... National Institute of Standards and Technology (NIST) and the ... and monitor the tiny amount of light reflected directly ... probe, and in so doing has demonstrated a 100-fold ... ambient conditions. Their recently reported work* potentially affects a ...
Cached Biology News:4,000-year-old coral beds among world's oldest living things, prof says 2Call for abstracts and registration for the EMBO Meeting 2009 2Making a point: Picoscale stability in a room-temperature AFM 2
EPA II Buffer is a diluent formulated to stabilize the activity of Chemicon horseradish peroxidase (HRP)-antibody conjugates at high conjugate dilution for extended periods....
... its SpliceArray service, ExonHit can design custom ... with your gene list. Proprietary algorithms ... design microarray probes from high quality, spliced ... splice event contained in a custom SpliceArray ...
... DX's sensitivity of DNA detection has been improved. ... an agarose gel can be detected > 20 ... be purified by organic solvent extraction or with ... worked well.) DNA excised from agarose gel ...
... The RapidTrace SPE Workstation is a modular, ... extraction platform. Utilizing 1ml or 3ml industry ... up to 100 samples in less than ... loaded with 10 cartridges, and up to ...
Biology Products: